198 related articles for article (PubMed ID: 32466374)
1. The Potential of CD16 on Plasma-Derived Exosomes as a Liquid Biomarker in Head and Neck Cancer.
Hofmann L; Ludwig S; Schuler PJ; Hoffmann TK; Brunner C; Theodoraki MN
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32466374
[TBL] [Abstract][Full Text] [Related]
2. CD44v3 protein-carrying tumor-derived exosomes in HNSCC patients' plasma as potential noninvasive biomarkers of disease activity.
Theodoraki MN; Matsumoto A; Beccard I; Hoffmann TK; Whiteside TL
Oncoimmunology; 2020; 9(1):1747732. PubMed ID: 32313730
[TBL] [Abstract][Full Text] [Related]
3. Clinical Significance of PD-L1
Theodoraki MN; Yerneni SS; Hoffmann TK; Gooding WE; Whiteside TL
Clin Cancer Res; 2018 Feb; 24(4):896-905. PubMed ID: 29233903
[TBL] [Abstract][Full Text] [Related]
4. Separation of plasma-derived exosomes into CD3
Theodoraki MN; Hoffmann TK; Whiteside TL
Clin Exp Immunol; 2018 Jun; 192(3):271-283. PubMed ID: 29431869
[TBL] [Abstract][Full Text] [Related]
5. Plasma‑derived CD16 exosomes and peripheral blood monocytes as correlating biomarkers in head and neck cancer.
Theodoraki MN; Hofmann L; Huber D; Brunner C; Hoffmann TK; Idel C; Fleckner J; Bruchhage KL; Pries R
Oncol Lett; 2023 May; 25(5):200. PubMed ID: 37113401
[TBL] [Abstract][Full Text] [Related]
6. Exosomes in HNSCC plasma as surrogate markers of tumour progression and immune competence.
Theodoraki MN; Hoffmann TK; Jackson EK; Whiteside TL
Clin Exp Immunol; 2018 Oct; 194(1):67-78. PubMed ID: 30229863
[TBL] [Abstract][Full Text] [Related]
7. NET-producing CD16
Millrud CR; Kågedal Å; Kumlien Georén S; Winqvist O; Uddman R; Razavi R; Munck-Wikland E; Cardell LO
Int J Cancer; 2017 Jun; 140(11):2557-2567. PubMed ID: 28247912
[TBL] [Abstract][Full Text] [Related]
8. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
[TBL] [Abstract][Full Text] [Related]
9. Exosomes from HNSCC Promote Angiogenesis through Reprogramming of Endothelial Cells.
Ludwig N; Yerneni SS; Razzo BM; Whiteside TL
Mol Cancer Res; 2018 Nov; 16(11):1798-1808. PubMed ID: 30042174
[TBL] [Abstract][Full Text] [Related]
10. The Emerging Role of Exosomes in Diagnosis, Prognosis, and Therapy in Head and Neck Cancer.
Hofmann L; Ludwig S; Vahl JM; Brunner C; Hoffmann TK; Theodoraki MN
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32517240
[TBL] [Abstract][Full Text] [Related]
11. Cargo and Functional Profile of Saliva-Derived Exosomes Reveal Biomarkers Specific for Head and Neck Cancer.
Hofmann L; Medyany V; Ezić J; Lotfi R; Niesler B; Röth R; Engelhardt D; Laban S; Schuler PJ; Hoffmann TK; Brunner C; Jackson EK; Theodoraki MN
Front Med (Lausanne); 2022; 9():904295. PubMed ID: 35899209
[TBL] [Abstract][Full Text] [Related]
12. Circulating exosomes measure responses to therapy in head and neck cancer patients treated with cetuximab, ipilimumab, and IMRT.
Theodoraki MN; Yerneni S; Gooding WE; Ohr J; Clump DA; Bauman JE; Ferris RL; Whiteside TL
Oncoimmunology; 2019; 8(7):1593805. PubMed ID: 31143513
[No Abstract] [Full Text] [Related]
13. [Exosomes: potential liquid biopsy in head and neck cancer].
Theodoraki MN; Ludwig S
HNO; 2020 Feb; 68(2):106-110. PubMed ID: 31915880
[TBL] [Abstract][Full Text] [Related]
14. Purine Metabolites in Tumor-Derived Exosomes May Facilitate Immune Escape of Head and Neck Squamous Cell Carcinoma.
Ludwig N; Gillespie DG; Reichert TE; Jackson EK; Whiteside TL
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32560461
[TBL] [Abstract][Full Text] [Related]
15. TGFβ carrying exosomes in plasma: potential biomarkers of cancer progression in patients with head and neck squamous cell carcinoma.
Ludwig N; Yerneni SS; Harasymczuk M; Szczepański MJ; Głuszko A; Kukwa W; Jordan T; Spanier G; Taxis J; Spoerl S; Meier JK; Hinck CS; Campbell PG; Reichert TE; Hinck AP; Whiteside TL
Br J Cancer; 2023 May; 128(9):1733-1741. PubMed ID: 36810911
[TBL] [Abstract][Full Text] [Related]
16. Tumor-derived exosomes promote angiogenesis via adenosine A
Ludwig N; Yerneni SS; Azambuja JH; Gillespie DG; Menshikova EV; Jackson EK; Whiteside TL
Angiogenesis; 2020 Nov; 23(4):599-610. PubMed ID: 32419057
[TBL] [Abstract][Full Text] [Related]
17. Squamous cell carcinoma antigen as a prognostic marker and its correlation with clinicopathological features in head and neck squamous cell carcinoma: Systematic review and meta-analysis.
Travassos DC; Fernandes D; Massucato EMS; Navarro CM; Bufalino A
J Oral Pathol Med; 2018 Jan; 47(1):3-10. PubMed ID: 28600896
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy: An emerging prognostic and predictive tool in Head and Neck Squamous Cell Carcinoma (HNSCC). Focus on Circulating Tumor Cells (CTCs).
Economopoulou P; Kotsantis I; Kyrodimos E; Lianidou ES; Psyrri A
Oral Oncol; 2017 Nov; 74():83-89. PubMed ID: 29103757
[TBL] [Abstract][Full Text] [Related]
19. Gene expression profiling of circulating natural killer cells in head and neck squamous cell carcinoma.
Böttcher A; Ostwald J; Koczan D; Knecht R; Kramp B; Dommerich S
Cancer Genomics Proteomics; 2013; 10(5):197-207. PubMed ID: 24136972
[TBL] [Abstract][Full Text] [Related]
20. Differential Immunomodulatory Effects of Head and Neck Cancer-Derived Exosomes on B Cells in the Presence of ATP.
Coray M; Göldi V; Schmid L; Benecke L; Figueiró F; Muller L
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
